Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Stigma of migraine is significant; worse for those with chronic migraine

23.06.2010
Researchers looking for the first time at how migraine sufferers experience the stigmatizing effects of their disease show that chronic migraine sufferers experience worse stigma than episodic migraine sufferers and more than those with other neurological diseases including stroke, epilepsy and MS.

The research[i], presented at the American Headache Society's 52nd Annual Scientific Meeting in Los Angeles this week, was conducted at the Jefferson Headache Clinic at Thomas Jefferson University Hospital in Philadelphia by Jung E. Park, MD and her team.

"Many diseases like HIV, mental illness, and cancer can be highly stigmatizing, resulting in depression, anxiety, decreased quality of life, and disruption of social relationships," said Dr. Park. "Our goal was to understand how stigma attaches to migraine."

The team surveyed 123 outpatients with chronic migraine (CM) and 123 with episodic migraine (EM) ages 18 to 65 using the Stigma Scale for Chronic Illness (SSCI), a recently developed 24-item instrument that allows for the quantitative assessment of stigma in persons with neurological disorders and comparisons across disorders, the Migraine Disability Scale (MIDAS), and the SF-12, a quality of life measure.

"The SSCI was markedly different in EM vs. CM (41.6±14.84 vs. 54.05±20.15, (p
"It is as important to understand the impact of migraine on patient quality of life as it is to understand its medical and physiological impact," said David Dodick, M.D., president of the AHS. "Our hope is that work like this will ultimately aid in the development of public health strategies to combat the stigmatizing effects of migraine." Dr Park agrees, and hopes that by understanding what drives the stigmatizing effect, and perhaps what protects certain individuals from feeling stigmatized we can improve the lives of persons with migraine. To round out the picture we should eventually understand stigmatization not just from the patient's perspective but also the attitudes of the families, employers and acquaintances who stigmatize persons with migraine, rounding out the picture and in order to devise more effective public health strategies.

More than 200 scientific papers and posters are being presented during the AHS meeting which is expected to draw some 500 migraine and headache health professionals including doctors, researchers and specialists.

About the American Headache Society

The American Headache Society® (AHS) is a professional society of health care providers dedicated to the study and treatment of headache and face pain. The Society's objectives are to promote the exchange of information and ideas concerning the causes and treatments of headache and related painful disorders. Educating physicians, health professionals and the public and encouraging scientific research are the primary functions of this organization. AHS activities include an annual scientific meeting, a comprehensive headache symposium, regional symposia for neurologists and family practice physicians, publication of the journal Headache and sponsorship of the AHS Committee for Headache Education (ACHE). www.americanheadachesociety.org

About the American Migraine Foundation

The American Migraine Foundation is a non-profit foundation supported by the American Headache Society and generous donors dedicated to the advancement of migraine research. The mission of this newly formed foundation is to support innovative research that will lead to improvement in the lives of those who suffer from migraine and other disabling headaches. www.americanmigrainefoundation.org

CONTACT:

Lauren Martiello
M Booth & Associates
212-539-3291
laurenm@mbooth.com
Martha Cid
M Booth & Associates
212-539-3258
marthac@mbooth.com
[i] Title: The Stigma of Migraine
Authors: 1. Jung E Park1 , MD
2. Joanna Kempner2 , PhD
3. William B Young1 , MD
1. Thomas Jefferson University, Neurology, Philadelphia, PA, 19107, United States

2. Rutgers, The State University, Department of Sociology, New Brunswick, NJ, 08854, United States

Objectives: To characterize stigma in patients with chronic and episodic migraines.

Background: Stigma is an established construct in the social sciences that describes an attribute, trait or disorder that is deeply discrediting and may elicit some form of community sanction. Research has shown many diseases, like HIV, mental illness, and cancer, can be highly stigmatizing, resulting in depression, anxiety, decreased quality of life, and disruption of social relationships. But stigma attaches to disease to varying degrees. To date, there has been no research on stigma in people with migraine. This study will look at stigma in both chronic and episodic migraine patients, in order to understand how stigma attaches to migraine. This effort will ultimately aid in the development of public health strategies to combat the stigmatizing effects of migraine. Methods: We conducted a survey among outpatients at the Jefferson Headache Clinic in the department of Neurology at Thomas Jefferson University Hospital. 123 patients with chronic migraine(CM) and 123 patients with episodic migraine(EM) age 18 to 65 were assessed for basic demographic information, given the Stigma Scale for Chronic Illness (SSCI), and the Migraine Disability Scale (MIDAS). The Stigma Scale for Chronic Illness (SSCI) is a recently developed 24-item instrument that allows for the quantitative assessment of stigma in persons with neurological disorders and comparisons across disorders. Results: The average age of study participants was 42.8, which differed for EM and CM (44.7±12.5 vs. 40.9±12.2, p=0.016). 91.5% of patients were white and 84% female. Chronic migaineurs had slightly lower educational achievements and significantly lower incomes (p=0.13 and p

The SSCI was markedly different in EM vs. CM, 41.6±14.84 vs

Lauren Martiello | EurekAlert!
Further information:
http://www.americanmigrainefoundation.org
http://www.americanheadachesociety.org

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>